FDA Clearance Tracker · P000025-S122
MED-EL Cochlear Implant System
Last checked: Nov 20, 2026Latest source record: Sep 3, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Sep 3, 2021
Approved
Time to decision
112 days
Received May 14, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P000025-S122
- Device name
- MED-EL Cochlear Implant System
- Applicant
- Med-El Corp.
- Applicant location
- Innsbruck
- Received
- May 14, 2021
- Decided
- Sep 3, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P000025
Device type
- Device type
- Implant, cochlear (MCM)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
Approval for a new sterilization site located at Exlgasse 20, Innsbruck, 6020, Austria for sterilization of cochlear implants and surgical accessories
Source documents
Other decisions for Med-El Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MED-EL CI SystemPMA supplement
P000025-S134 · Decided Nov 26, 2025 · 287 days after receipt · Panel Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.